HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$20.05
Day range
$19.59 - $20.23
Year range
$5.63 - $26.35
Market cap
1.81B USD
Avg Volume
186.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 1.40M | -70.70% |
Operating expense | 56.88M | 31.36% |
Net income | -93.77M | -149.71% |
Net profit margin | -6.69K | -752.14% |
Earnings per share | -0.99 | — |
EBITDA | -55.47M | -44.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 481.15M | 25.46% |
Total assets | 488.46M | 3.69% |
Total liabilities | 76.66M | 56.98% |
Total equity | 411.80M | — |
Shares outstanding | 88.46M | — |
Price to book | 4.30 | — |
Return on assets | -33.20% | — |
Return on capital | -39.61% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -93.77M | -149.71% |
Cash from operations | -54.60M | -73.72% |
Cash from investing | -385.00K | -114.89% |
Cash from financing | 198.18M | 4,840.30% |
Net change in cash | 140.70M | 611.37% |
Free cash flow | -25.53M | -126.16% |
About
Founded
2019
Website
Employees
29
